Kentaro Tochitani
Overview
Explore the profile of Kentaro Tochitani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yogo A, Yamamoto S, Tochitani K
J Gen Fam Med
. 2024 Jul;
25(4):206-213.
PMID: 38966654
Background: We aimed to aid the appropriate use of antimicrobial agents by determining the timing of secondary bacteremia and validating and updating clinical prediction models for bacteremia in patients with...
2.
Shiroshita A, Tochitani K, Maki Y, Terayama T, Kataoka Y
Antibiotics (Basel)
. 2024 May;
13(5).
PMID: 38786112
Evidence on the optimal antibiotic strategy for empyema is lacking. Our database study aimed to evaluate the effectiveness of empirical anti-pseudomonal antibiotics in patients with empyema. We utilised a Japanese...
3.
Kataoka Y, Baba T, Ikenoue T, Matsuoka Y, Matsumoto J, Kumasawa J, et al.
Ann Clin Epidemiol
. 2024 Mar;
4(4):110-119.
PMID: 38505255
Background: We aimed to develop and externally validate a novel machine learning model that can classify CT image findings as positive or negative for SARS-CoV-2 reverse transcription polymerase chain reaction...
4.
Arashiro T, Miwa M, Nakagawa H, Takamatsu J, Oba K, Fujimi S, et al.
Vaccine
. 2023 Dec;
42(3):677-688.
PMID: 38114409
Introduction: Since the SARS-CoV-2 Omicron variant became dominant, assessing COVID-19 vaccine effectiveness (VE) against severe disease using hospitalization as an outcome became more challenging due to incidental infections via admission...
5.
Sumiyoshi S, Aoki K, Motobayashi H, Yogo A, Tochitani K
Diagn Microbiol Infect Dis
. 2023 Nov;
108(1):116110.
PMID: 37924747
When rare bacterial species are identified in blood cultures, determining the clinical significance is sometimes difficult. This study aimed to analyze the clinical significance of rare bacterial species detected in...
6.
Yogo A, Sumiyoshi S, Aoki K, Motobayashi H, Tochitani K, Yamamoto S, et al.
Antimicrob Steward Healthc Epidemiol
. 2023 Jan;
3(1):e18.
PMID: 36714282
No abstract available.
7.
Motobayashi H, Sumiyoshi S, Aoki K, Yogo A, Tochitani K, Yamamoto S, et al.
IDCases
. 2022 Nov;
31:e01648.
PMID: 36447935
infections, which can be asymptomatic, are endemic to developing countries; traveling to such countries is a risk factor for contracting these infections. A 65-year-old Japanese man was hospitalized for coronavirus...
8.
Uneno Y, Imura H, Makuuchi Y, Tochitani K, Watanabe N
Cochrane Database Syst Rev
. 2022 Nov;
11:CD013604.
PMID: 36440894
Background: Intensive cytotoxic chemotherapy for people with cancer can cause severe and prolonged cytopenia, especially neutropenia, a critical condition that is potentially life-threatening. When manifested by fever and neutropenia, it...
9.
Katasako A, Sasaki S, Raita Y, Yamamoto S, Tochitani K, Murakami M, et al.
BMJ Open
. 2022 Oct;
12(10):e058666.
PMID: 36207044
Objectives: Elevated baseline serum alkaline phosphatase (ALP) may correlate with higher medium-term to long-term mortality in the general population and in patients with chronic kidney disease. However, few data are...
10.
Yogo A, Yamamoto S, Sumiyoshi S, Iwamoto N, Aoki K, Motobayashi H, et al.
J Infect Chemother
. 2022 May;
28(8):1189-1192.
PMID: 35525700
Background: Staphylococcus epidermidis is a common cause of health care-associated bacteremia, especially in patients with an indwelling medical device. However, S. epidermidis is an uncommon causative organism in catheter-associated urinary...